Matinas BioPharma Holdings, Inc.
MTNB
$0.87
-$0.01-1.14%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.63% | -5.71% | 0.61% | -10.85% | -13.25% |
| Total Depreciation and Amortization | -9.66% | 3.29% | 4.10% | 4.35% | 3.93% |
| Total Amortization of Deferred Charges | 30.77% | -- | -100.00% | -100.00% | -113.40% |
| Total Other Non-Cash Items | 37.08% | 48.83% | -17.29% | -15.79% | -8.83% |
| Change in Net Operating Assets | -3.57% | -107.86% | -675.00% | 67.72% | 113.65% |
| Cash from Operations | 28.52% | -3.97% | -13.04% | -14.95% | 8.26% |
| Capital Expenditure | -- | -- | 100.00% | 96.76% | 37.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.15% | -31.59% | 11.12% | -79.73% | 136.75% |
| Cash from Investing | -41.12% | -30.46% | 13.95% | -79.16% | 149.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.00% | 28.57% | 54.55% | 69.23% | 77.78% |
| Issuance of Common Stock | 16,918.52% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21,436.00% | 131,157.14% | 83,500.00% | 71,176.92% | 377.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.39% | 222.22% | 181.53% | -742.53% | 65.65% |